Rab 14 Inhibitors
Rab 14 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Rab14, a member of the Rab family of small GTPases. Rab proteins are critical regulators of intracellular vesicle trafficking, and Rab14, in particular, plays a significant role in the regulation of endocytic and secretory pathways. Rab14 is involved in the trafficking of vesicles between the Golgi apparatus, endosomes, and the plasma membrane, influencing processes such as membrane recycling, protein sorting, and the transport of cargo proteins to specific cellular locations. By facilitating these trafficking events, Rab14 is essential for maintaining the proper distribution of proteins and lipids within cells, which is crucial for various cellular functions, including cell signaling, growth, and differentiation. Inhibiting Rab14 disrupts these trafficking processes, offering researchers a tool to study the specific roles of Rab14 in vesicular transport and its broader impact on cellular organization and function.
In research, Rab14 inhibitors are valuable for dissecting the molecular mechanisms by which Rab14 regulates vesicle trafficking and the implications of these processes for cellular physiology. By blocking Rab14 activity, scientists can investigate how the inhibition affects the dynamics of vesicle formation, movement, and fusion, particularly in the context of endosome-Golgi and endosome-plasma membrane trafficking pathways. This inhibition allows researchers to explore the role of Rab14 in the sorting and delivery of membrane proteins, the recycling of cell surface receptors, and the maintenance of cellular homeostasis. Additionally, Rab14 inhibitors provide insights into the interactions between Rab14 and its effector proteins, shedding light on the complex networks that govern vesicle trafficking and membrane dynamics. Through these studies, the use of Rab14 inhibitors enhances our understanding of the essential functions of Rab GTPases in cellular organization, the regulation of intracellular transport, and the broader implications of vesicle trafficking for cell signaling and membrane biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in intracellular signaling. Rab 14 is known to participate in endocytic pathways, which are regulated by PI3K activity. By inhibiting PI3K, wortmannin can disrupt the endocytic pathways, potentially modulating Rab 14 activity by altering vesicle trafficking and membrane dynamics. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK (Rho-associated protein kinase). ROCK is involved in actin cytoskeleton organization, influencing cellular processes like vesicle trafficking, in which Rab 14 plays a role. By inhibiting ROCK, Y-27632 can alter cytoskeleton dynamics, potentially impacting Rab 14-mediated vesicular transport and membrane fusion events. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, a kinase involved in the MAPK/ERK pathway. This pathway influences various cellular processes including endocytosis and vesicle trafficking, where Rab 14 is active. Inhibition of MEK by PD98059 may lead to altered signaling dynamics in these pathways, potentially modulating Rab 14 activity indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of PI3K, similar in function to Wortmannin but with different binding properties. By inhibiting PI3K, LY294002 disrupts intracellular signaling pathways involved in vesicle formation and trafficking, processes in which Rab 14 is a key player. This can lead to altered Rab 14 activity in these pathways. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö6983 is a broad-spectrum inhibitor of protein kinase C (PKC) isoforms. PKC plays a role in various cellular processes, including those involving membrane dynamics and vesicle trafficking. By inhibiting PKC activity, Gö6983 can influence these cellular processes, indirectly affecting Rab 14's function in membrane trafficking. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective inhibitor of Cdc42, another Rho GTPase like Rac1. Cdc42 is involved in actin cytoskeleton organization, affecting vesicle transport and endocytosis. Inhibition of Cdc42 by ML141 can alter cytoskeleton dynamics and, consequently, Rab 14-mediated vesicular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK (c-Jun N-terminal kinase), a component of the MAPK signaling pathway. By inhibiting JNK, SP600125 can affect signaling pathways that regulate vesicle formation and trafficking, potentially influencing Rab 14's role in these processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. The p38 MAPK pathway is involved in stress responses and cytoskeletal reorganization. Inhibition of this pathway by SB203580 could lead to changes in cellular processes that affect Rab 14's function in vesicle trafficking and membrane dynamics. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor with broad specificity. Tyrosine kinases are involved in signaling pathways that regulate endocytosis and vesicle trafficking, processes where Rab 14 is active. By inhibiting these kinases, genistein can modulate signaling pathways, potentially affecting Rab 14 activity in vesicle dynamics. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is another inhibitor of PKC isoforms. Like Gö6983, it can disrupt PKC-mediated signaling pathways that play a role in vesicle formation and trafficking. This can indirectly modulate Rab 14's role in these cellular processes. | ||||||